Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Evogene Ltd.
  6. Company
    EVGN   IL0011050551

EVOGENE LTD.

(EVGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsRevisions 
Business Summary
Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd. (Evofuel). It operates through two segments. Its Evogene segment develops seed traits, ag-chemical products, and ag-biological products to improve plant performance. The Company's Evofuel segment develops species of the castor bean plant for second generation feedstock for biofuel and other industrial uses. Its Crop Enhancement (CE) division is developing two types of products: CE seed traits, are seed traits having improved yield and abiotic stress tolerance, and ag-biologicals, which focuses on microbial-based bio-stimulants. The Company's Crop Protection (CP) division is developing two types of products: CP seed traits and ag-chemicals.

Number of employees : 131 people.
Sales per Business
20192020Delta
ILS (in Million)%ILS (in Million)%
Agriculture2.3286.5%2.9181.4% +25.58%
Unallocated0.27110.1%0.2928.2% +7.95%
Human--0.2587.2%-
Industry0.0933.5%0.1133.2% +22.51%
Sales per region
2020
ILS (in Million)%
United States2.3265%
Israel0.78722%
Brazil0.39311%
Others0.0722%
Managers
NameAgeSinceTitle
Ofer Haviv542007President & Chief Executive Officer
Dorit Kreiner492019Chief Financial Officer
Mark Kapel442018Executive Vice President-Technology
Eyal Emmanuel, Dr.472019Chief Scientific Officer
Martin S. Gerstel792004Chairman
Leon Y. Recanati722005Independent Director
Ziv Kop502014Independent Director
Sarit Firon542016Independent Director
Adrian Percy552019Independent Director
Oded Shoseyov, Dr.642018Independent Director
Members of the board
NameAgeSinceTitle
Martin S. Gerstel792004Chairman
Leon Y. Recanati722005Independent Director
Ziv Kop502014Independent Director
Sarit Firon542016Independent Director
Adrian Percy552019Independent Director
Oded Shoseyov, Dr.642018Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 40,414,229 32,190,929 79.7% 0 0.0% 79.7%
Shareholders
Company contact information
Evogene Ltd.
13 Gad Feinstein Street
Park Rehovot
Rehovot, HaMerkaz 76121

Phone : +972.8.931.1900
Fax : +972.8.946.6724
Web : http://www.evogene.com
Sector Other Pharmaceuticals
1st jan.Capitalization (M$)
EVOGENE LTD.-21.37%152
JOHNSON & JOHNSON6.58%439 961
ROCHE HOLDING AG-2.98%283 498
PFIZER, INC.8.58%222 959
ABBVIE INC.8.33%204 332
MERCK & CO., INC.-4.91%196 682
NOVARTIS AG-5.70%193 868
ELI LILLY AND COMPANY14.84%175 269
NOVO NORDISK A/S7.64%170 766
BRISTOL-MYERS SQUIBB COMPANY4.27%144 420
AMGEN INC.8.45%143 265
ASTRAZENECA PLC4.86%140 130
SANOFI7.12%126 979
GLAXOSMITHKLINE PLC0.16%93 240
JIANGSU HENGRUI MEDICINE CO., LTD.-26.32%68 972
ALLERGAN PLC0.97%63 659
BAYER AG11.95%63 070
CHUGAI PHARMACEUTICAL CO., LTD.-25.48%61 703
TAKEDA PHARMACEUTICAL COMPANY LIMITED-3.20%52 050
DAIICHI SANKYO COMPANY, LIMITED-21.16%48 876
CHANGCHUN HIGH & NEW TECHNOLOGY INDUSTRY (GROUP) INC.10.85%31 110